CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: BIO 2016 (619) Smart Money VCs (6326) Pharma Startups (6570) Cancer Therapeutics (1180)
Five Prime Therapeutics is a clinical-stage biotechnology company with a pipeline of antibodies and ligand traps for cancer, autoimmunity and respiratory diseases. FivePrime has differentiated discovery capabilities built on its library of secreted a...Show all
Company (IPO / Went public)
Phone: 415-365-5600
Two Corporate Drive
South San Francisco, 94080
California, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Five Prime Therapeutics | $75M | Sep 18, 2013 |
| Xenon Pharmaceuticals | $134.7M | Nov 5, 2014 |
| Caprion Pharmaceuticals | $1.9M | Mar 19, 2007 |
| See all 20 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Antibodies that bind colony stimulating factor 1 receptor (csf1r) | Sep 29, 2016 | May 01, 2018 | Patent |
| Methods of treating mesothelioma by administration of compounds comprising fgfr1 ecd | May 22, 2014 | Oct 03, 2017 | Patent |
| Anti-csfr1 antibody and anti pd-1 antibody combination therapy for cancer | Oct 28, 2015 | Sep 19, 2017 | Patent |
| Antibodies that bind colony stimulating factor 1 receptor (csf1r) | Oct 27, 2015 | Jul 04, 2017 | Patent |
| Treatment of cancer with elevated dosages of soluble fgfr1 fusion proteins | Nov 24, 2014 | Oct 25, 2016 | Patent |
